Investigating the therapeutic potential of FTY720 for Human African Trypanosomiasis.

Project: Research

Status	Finished
Effective start/end date	1/01/14 → 31/12/16

Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
Stoessel, D., Nowell, C. J., Jones, A. J., Ferrins, L., Ellis, K. M., Riley, J., Rahmani, R., Read, K. D., McConville, M. J., Avery, V. M., Baell, J. B. & Creek, D. J., 1 Jul 2016, In: Metabolomics. 12, 7, 14 p., 126.
Research output: Contribution to journal › Article › Research › peer-review

14 Citations (Scopus)

Project Details